Symrise and India’s Virchow Group have agreed to make personal care ingredients from the Symrise portfolio through a new joint venture called Vizag Care Ingredients, beginning within 1H. This will be based on Virchow’s synthetic chemistry capabilities for API manufacture.

Symrise owns a majority in the new entity, which is based in Visakhapatnam and has one local chemical manufacturing site, enabling it to back-integrate into raw materials and form a resilient global value chain. Symrise will market the resulting products.

The EU Court of Justice (CJEU) in Luxembourg has dismissed an action by Symrise to annul a decision by the European Chemicals Agency (ECHA) board of appeal in 2021. The long-running case related to a required compliance check using animal tests on Symrise’s REACH registration dossier for the UV fillers homosalate and 2-ethylhexyl salicylate.

Symrise has made an unspecified investment to take a minority stake in Israeli biotech Synergio, with the option of owning a majority in future. Financial terms are not being disclosed.

Based in Jerusalem, Synergio specialises in developing natural antimicrobial combinations from plants for product protection, using a data-driven, biochemistry-based, computational platform. Symrise is already a major player in this field within the personal care sector and sees growth opportunities in working together with Synergio.